市场调查报告书
商品编码
1468169
2024-2032 年按类型、技术、适应症、最终用户和地区分類的心臟起搏器市场Cardiac Pacemaker Market by Type, Technology, Indication, End User, and Region 2024-2032 |
IMARC Group年全球心臟节律器市场规模达50亿美元。心血管疾病盛行率不断上升、拥有健康保险的人数不断增加,以及为改善手术技术而进行的广泛研发 (R&D) 活动是推动市场发展的一些关键因素。
心臟节律器是一种植入胸部或腹部的小型医疗设备,利用电脉衝治疗心律不整,有助于调节和监测心跳。它具有电子和机械组件,例如微处理器、感测器、电极、电线、引线和外壳,并且可以根据患者的要求进行客製化。它有助于降低因心率不规则或缓慢引起的中风和心臟衰竭等併发症的风险。除此之外,心臟节律器也被整合到植入式除颤器和心臟再同步治疗装置中,以提供更全面的治疗方法。目前,主要参与者正在推出小型且侵入性较小的心臟起搏器,以使患者更容易耐受,也更容易让外科医生植入。
心血管疾病(CVD)在大众中的盛行率激增是推动全球心臟节律器需求的主要因素之一。此外,人口老化加剧,更容易罹患心律不整、先天性心臟病和心房颤动等疾病,有利于市场成长。此外,健康意识的增强以及对心臟相关疾病可用治疗替代方案的认识正在对市场产生积极影响。除此之外,越来越多的人拥有为心臟起搏器提供经济援助并减少医疗费用的健康保险,这也促进了市场的成长。此外,领先厂商正在推出具有更长电池寿命和远端监控功能的心臟起搏器,使医疗保健专业人员能够使用智慧型手机远端追踪设备的性能和患者的心臟功能。主要参与者也致力于在心臟节律器的製造中使用生物相容性材料,以尽量减少感染和与起搏器植入相关的其他併发症的风险。除此之外,将无线技术整合到心臟起搏器中以在设备之间传输资料,有助于提高设备的准确性和可靠性,正在推动市场的成长。此外,许多国家的管理机构正在投资研发 (R&D) 活动,以改善手术技术并提供便利的医疗设施。
The global cardiac pacemaker market size reached US$ 5.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.8 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032. The increasing prevalence of CVDs, rising number of people with health insurance policies, and extensive research and development (R&D) activities for improving surgical techniques represent some of the key factors driving the market.
A cardiac pacemaker is a small medical device implanted in the chest or abdomen to treat heart rhythm disorders using electrical pulses, which assist in regulating and monitoring the heartbeat. It has electronic and mechanical components, such as microprocessors, sensors, electrodes, wires, leads, and housing, and can be customized according to the requirements of the patient. It helps reduce the risk of complications like stroke and heart failure that can be caused by an irregular or slow heart rate. Besides this, a cardiac pacemaker is incorporated into implantable defibrillators and cardiac resynchronization therapy devices to offer a more comprehensive treatment approach. At present, key players are introducing small and less invasive cardiac pacemakers to make it easier for patients to tolerate and surgeons to implant.
The surging prevalence of cardiovascular diseases (CVDs) among the masses represents one of the major factors driving the demand for cardiac pacemakers around the world. Moreover, the rising aging population, which is more prone to ailments, such as arrhythmias, congenital heart disease, and atrial fibrillation, is favoring the market growth. In addition, the growing health consciousness and awareness about the available treatment alternatives for heart-related ailments are influencing the market positively. Apart from this, the increasing number of people with health insurance policies that provide financial assistance for cardiac pacemakers and reduce medical expenses is contributing to the market growth. Furthermore, leading players are launching cardiac pacemakers with longer battery life and remote monitoring capabilities that allow healthcare professionals to track the performance of the device and heart function of patients remotely using a smartphone. Key players are also focusing on using biocompatible materials in the manufacturing of cardiac pacemakers to minimize the risk of infection and other complications associated with pacemaker implantation. Besides this, the integration of wireless technology in cardiac pacemakers to transmit data to and from the device that can help improve the accuracy and reliability of the device is propelling the growth of the market. Additionally, governing agencies of numerous countries are investing in research and development (R&D) activities to improve surgical techniques and provide easy access to healthcare facilities.
IMARC Group provides an analysis of the key trends in each segment of the global cardiac pacemaker market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on type, technology, indication, and end user.
Implantable
External
The report has provided a detailed breakup and analysis of the cardiac pacemaker market based on the type. This includes implantable and external. According to the report, implantable represented the largest segment.
Biventricular
Single Chambered
Dual Chambered
Others
A detailed breakup and analysis of the cardiac pacemaker market based on the technology has also been provided in the report. This includes biventricular, single chambered, dual chambered, and others. According to the report, dual chambered accounted for the largest market share.
Arrhythmias
Congestive Heart Failure
Others
The report has provided a detailed breakup and analysis of the cardiac pacemaker market based on the indication. This includes arrhythmias, congestive heart failure, and others. According to the report, arrhythmias represented the largest segment.
Hospitals and Clinics
Ambulatory Surgery Centers
Others
A detailed breakup and analysis of the cardiac pacemaker market based on the end user has also been provided in the report. This includes hospitals and clinics, ambulatory surgery centers, and others. According to the report, hospitals and clinics accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for cardiac pacemaker. Some of the factors driving the North America cardiac pacemaker market included the growing incidences of cardiac disorders, rising geriatric population, the launch of MRI-compatible pacemakers and Bluetooth-enabled pacemakers, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global cardiac pacemaker market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Lepu Medical Technology (Beijing)Co. Ltd., MEDICO s.r.l., Medtronic plc, MicroPort Scientific Corporation, Oscor Inc. (Integer Holdings Corporation), Osypka Medical GmbH., Shree Pacetronix Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.